Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Estrogen Receptor Positive Breast Cancer × Estradiol × Breast × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 14 Neoplasm Metastasis 2 Vaginitis 1 Triple Negative Breast Neoplasms 1 Osteoporosis 1 Estrogen Receptor Positive Breast Cancer 1 Estrogen Levels Among Breast Cancer Patients 1 Coronary Disease 1 Cardiovascular Diseases 1 Breast Carcinoma In Situ 1 Atrophic Vaginitis 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Fulvestrant 2 vistusertib 1 capivasertib 1 Transurethral Resection of Bladder 1 Hydroxychloroquine 1 Everolimus 1 Estrogens 1 Estradiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02238808 2025-06-26

PRESTO

AHS Cancer Control Alberta

Phase 2 Active not recruiting

Estrogen Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡